These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 15956085

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Abnormal growth in noonan syndrome: the challenge of optimal therapy.
    Savage MO, Padidela R, Kirk JM, Malaquias AC, Jorge AA.
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():523-8. PubMed ID: 19550387
    [Abstract] [Full Text] [Related]

  • 24. PTPN11, RAS and FLT3 mutations in childhood acute lymphoblastic leukemia.
    Yamamoto T, Isomura M, Xu Y, Liang J, Yagasaki H, Kamachi Y, Kudo K, Kiyoi H, Naoe T, Kojma S.
    Leuk Res; 2006 Sep; 30(9):1085-9. PubMed ID: 16533526
    [Abstract] [Full Text] [Related]

  • 25. Impact of Growth Hormone Therapy on Adult Height in Patients with PTPN11 Mutations Related to Noonan Syndrome.
    Malaquias AC, Noronha RM, Souza TTO, Homma TK, Funari MFA, Yamamoto GL, Silva FV, Moraes MB, Honjo RS, Kim CA, Nesi-França S, Carvalho JAR, Quedas EPS, Bertola DR, Jorge AAL.
    Horm Res Paediatr; 2019 Sep; 91(4):252-261. PubMed ID: 31132774
    [Abstract] [Full Text] [Related]

  • 26. Spectrum of mutations in PTPN11 and genotype-phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome.
    Musante L, Kehl HG, Majewski F, Meinecke P, Schweiger S, Gillessen-Kaesbach G, Wieczorek D, Hinkel GK, Tinschert S, Hoeltzenbein M, Ropers HH, Kalscheuer VM.
    Eur J Hum Genet; 2003 Feb; 11(2):201-6. PubMed ID: 12634870
    [Abstract] [Full Text] [Related]

  • 27. Genetics and variation in phenotype in Noonan syndrome.
    Jongmans M, Otten B, Noordam K, van der Burgt I.
    Horm Res; 2004 Feb; 62 Suppl 3():56-9. PubMed ID: 15539800
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. IGF-I generation test in prepubertal children with Noonan syndrome due to mutations in the PTPN11 gene.
    Bertelloni S, Baroncelli GI, Dati E, Ghione S, Baldinotti F, Toschi B, Simi P.
    Hormones (Athens); 2013 Feb; 12(1):86-92. PubMed ID: 23624134
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mutational analysis of the PTPN11 gene in Egyptian patients with Noonan syndrome.
    Essawi ML, Ismail MF, Afifi HH, Kobesiy MM, El Kotoury A, Barakat MM.
    J Formos Med Assoc; 2013 Nov; 112(11):707-12. PubMed ID: 24183200
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Functional analysis of PTPN11/SHP-2 mutants identified in Noonan syndrome and childhood leukemia.
    Niihori T, Aoki Y, Ohashi H, Kurosawa K, Kondoh T, Ishikiriyama S, Kawame H, Kamasaki H, Yamanaka T, Takada F, Nishio K, Sakurai M, Tamai H, Nagashima T, Suzuki Y, Kure S, Fujii K, Imaizumi M, Matsubara Y.
    J Hum Genet; 2005 Nov; 50(4):192-202. PubMed ID: 15834506
    [Abstract] [Full Text] [Related]

  • 34. Mild variable Noonan syndrome in a family with a novel PTPN11 mutation.
    Zenker M, Voss E, Reis A.
    Eur J Med Genet; 2007 Nov; 50(1):43-7. PubMed ID: 17052965
    [Abstract] [Full Text] [Related]

  • 35. Mutational analysis of PTPN11 gene in Taiwanese children with Noonan syndrome.
    Hung CS, Lin JL, Lee YJ, Lin SP, Chao MC, Lo FS.
    J Formos Med Assoc; 2007 Feb; 106(2):169-72. PubMed ID: 17339163
    [Abstract] [Full Text] [Related]

  • 36. The mutational spectrum of PTPN11 in juvenile myelomonocytic leukemia and Noonan syndrome/myeloproliferative disease.
    Kratz CP, Niemeyer CM, Castleberry RP, Cetin M, Bergsträsser E, Emanuel PD, Hasle H, Kardos G, Klein C, Kojima S, Stary J, Trebo M, Zecca M, Gelb BD, Tartaglia M, Loh ML.
    Blood; 2005 Sep 15; 106(6):2183-5. PubMed ID: 15928039
    [Abstract] [Full Text] [Related]

  • 37. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST, Ki CS, Lee HJ.
    Clin Genet; 2007 Aug 15; 72(2):150-5. PubMed ID: 17661820
    [Abstract] [Full Text] [Related]

  • 38. PTPN11 mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13.
    Maheshwari M, Belmont J, Fernbach S, Ho T, Molinari L, Yakub I, Yu F, Combes A, Towbin J, Craigen WJ, Gibbs R.
    Hum Mutat; 2002 Oct 15; 20(4):298-304. PubMed ID: 12325025
    [Abstract] [Full Text] [Related]

  • 39. The Growth Characteristics of Patients with Noonan Syndrome: Results of Three Years of Growth Hormone Treatment: A Nationwide Multicenter Study.
    Şıklar Z, Genens M, Poyrazoğlu Ş, Baş F, Darendeliler F, Bundak R, Aycan Z, Savaş Erdeve Ş, Çetinkaya S, Güven A, Abalı S, Atay Z, Turan S, Kara C, Can Yılmaz G, Akyürek N, Abacı A, Çelmeli G, Sarı E, Bolu S, Korkmaz HA, Şimşek E, Çatlı G, Büyükinan M, Çayır A, Evliyaoğlu O, İşgüven P, Özgen T, Hatipoğlu N, Elhan AH, Berberoğlu M.
    J Clin Res Pediatr Endocrinol; 2016 Sep 01; 8(3):305-12. PubMed ID: 27125300
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.